PRIX GALIEN UK
The 2024 edition of the Prix Galien UK Awards were a true celebration of life sciences innovation
On 30 May, the industry’s best and brightest came together to spark discussion about the challenges facing the human condition, and specifically those in which the UK life sciences industry is most active. The Galien UK form was permeated by challenging discussion in the presence of representatives of patient groups, regulators, and industry representing both the European and American perspective on the future of life sciences research. The Awards ceremony which followed celebrated the wondrous achievements of the UK’s robust life sciences industry and introduced six new laureates into the Prix Galien Hall of Fame.
Prof. Sir Munir PIRMOHAMED
Prix Galien UK Committee Chair
Best Pharmaceutical Product
Amicus Therapeutics - Pombiliti® with Opfolda® (PomOp)
Best Biotechnology Product
Qdenga - Takeda UK Ltd.
VYVGART® - ArgenX
Best Medical Technology
MSIntuit® CRC - Owkin
Best Digital Health Solution
Medable Evidence Generation Platform -Medable
Best Public Sector Innovation
PRINCIPLE and PANORAMIC Trials - University of Oxford
“These individuals and organisations embody the essence of healthcare excellence, demonstrating profound dedication to improving the human condition. Their remarkable contributions serve as beacons of hope and progress, shaping the future of healthcare for generations to come," said Professor Sir Munir Pirmohamed, Chair of the Prix Galien UK Committee.
Prix Galien UK 2024 Winners
Prix Galien UK 2024 Awards Ceremony
Preceding the Awards Ceremony, the Prix Galien UK Forum brought forth a day-long exchange on the most significant challenges facing humanity in the realm of disease while highlighting the latest research and clinical pathways toward diagnosis, treatment, and cure. Among the topics discussed in the 2024 edition of the forum:
- No decision for me without me: Putting Patients at the heart of drug dvpt
- Introducing New Technologies: Optimising pathways to improve population health
- Can we use artificial intelligence to design new drugs?
- Innovation in R&D:The Birth of Breakthroughs
- Data Driven Medicine: The NHS as a strategic partner in Life Sciences
- Improving global health outcomes through clinical innovation
The Prix Galien UK judging panel comprises numerous of the UK’s leading luminaries in healthcare. The distinguished panel is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health globally.